In addition, the expression level of phospho-ERK1/2 (p-ERK1/2) in IFN-γ-stimulated NSCLC cells was significantly higher than that in the non-stimulated NSCLC cells (Figure 5B). The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.